Literature DB >> 26193487

Zeb2: A multifunctional regulator of nervous system development.

Shane V Hegarty1, Aideen M Sullivan2, Gerard W O'Keeffe2.   

Abstract

Zinc finger E-box binding homeobox (Zeb) 2 is a transcription factor, identified due its ability to bind Smad proteins, and consists of multiple functional domains which interact with a variety of transcriptional co-effectors. The complex nature of the Zeb2, both at its genetic and protein levels, underlie its multifunctional properties, with Zeb2 capable of acting individually or as part of a transcriptional complex to repress, and occasionally activate, target gene expression. This review introduces Zeb2 as an essential regulator of nervous system development. Zeb2 is expressed in the nervous system throughout its development, indicating its importance in neurogenic and gliogenic processes. Indeed, mutation of Zeb2 has dramatic neurological consequences both in animal models, and in humans with Mowat-Wilson syndrome, which results from heterozygous ZEB2 mutations. The mechanisms by which Zeb2 regulates the induction of the neuroectoderm (CNS primordium) and the neural crest (PNS primordium) are reviewed herein. We then describe how Zeb2 acts to direct the formation, delamination, migration and specification of neural crest cells. Zeb2 regulation of the development of a number of cerebral regions, including the neocortex and hippocampus, are then described. The diverse molecular mechanisms mediating Zeb2-directed development of various neuronal and glial populations are reviewed. The role of Zeb2 in spinal cord and enteric nervous system development is outlined, while its essential function in CNS myelination is also described. Finally, this review discusses how the neurodevelopmental defects of Zeb2 mutant mice delineate the developmental dysfunctions underpinning the multiple neurological defects observed in Mowat-Wilson syndrome patients.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Development; Epithelial–mesenchymal transition; Gliogenesis; Mowat–Wilson syndrome; Myelination; Nervous system; Neural crest; Neurogenesis; Smad; Zeb2

Mesh:

Substances:

Year:  2015        PMID: 26193487     DOI: 10.1016/j.pneurobio.2015.07.001

Source DB:  PubMed          Journal:  Prog Neurobiol        ISSN: 0301-0082            Impact factor:   11.685


  41 in total

1.  ZEB2 Attenuates LPS-Induced Inflammation by the NF-κB Pathway in HK-2 Cells.

Authors:  Qi Ding; Yang Wang; Ai-Ling Zhang; Tao Xu; Dan-Dan Zhou; Xiao-Feng Li; Jun-Fa Yang; Lei Zhang; Xiao Wang
Journal:  Inflammation       Date:  2018-03       Impact factor: 4.092

2.  Streptococcus gordonii programs epithelial cells to resist ZEB2 induction by Porphyromonas gingivalis.

Authors:  Jun Ohshima; Qian Wang; Zackary R Fitzsimonds; Daniel P Miller; Maryta N Sztukowska; Young-Jung Jung; Mikako Hayashi; Marvin Whiteley; Richard J Lamont
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-10       Impact factor: 11.205

3.  Loss of Zeb2 in mesenchyme-derived nephrons causes primary glomerulocystic disease.

Authors:  Hila Milo Rasouly; Sudhir Kumar; Stefanie Chan; Anna Pisarek-Horowitz; Richa Sharma; Qiongchao J Xi; Yuriko Nishizaki; Yujiro Higashi; David J Salant; Richard L Maas; Weining Lu
Journal:  Kidney Int       Date:  2016-08-31       Impact factor: 10.612

4.  Zeb2 Is a Regulator of Astrogliosis and Functional Recovery after CNS Injury.

Authors:  Ana L Vivinetto; Il-Doo Kim; David C Goldberg; Lilah Fones; Elizabeth Brown; Victor S Tarabykin; Caitlin E Hill; Sunghee Cho; John W Cave
Journal:  Cell Rep       Date:  2020-06-30       Impact factor: 9.423

5.  Zeb2: Inhibiting the inhibitors in Schwann cells.

Authors:  Bastian G Brinkmann; Susanne Quintes
Journal:  Neurogenesis (Austin)       Date:  2017-02-02

6.  KDM5B promotes cell migration by regulating the noncanonical Wnt/PCP pathway in Hirschsprung's disease.

Authors:  Ting Yao; Zhilin Xu; Zenghui Hao; You Yu; Bingxue Liang; Shuyu Wang
Journal:  Pediatr Surg Int       Date:  2021-08-29       Impact factor: 1.827

7.  Engineered microRNA-based regulatory element permits safe high-dose miniMECP2 gene therapy in Rett mice.

Authors:  Sarah E Sinnett; Emily Boyle; Christopher Lyons; Steven J Gray
Journal:  Brain       Date:  2021-11-29       Impact factor: 13.501

Review 8.  MicroRNAs Involved in Small-cell Lung Cancer as Possible Agents for Treatment and Identification of New Targets.

Authors:  Ulrich H Weidle; Adam Nopora
Journal:  Cancer Genomics Proteomics       Date:  2021 Sep-Oct       Impact factor: 4.069

9.  Genome-Wide Temporal Profiling of Transcriptome and Open Chromatin of Early Cardiomyocyte Differentiation Derived From hiPSCs and hESCs.

Authors:  Qing Liu; Chao Jiang; Jin Xu; Ming-Tao Zhao; Kevin Van Bortle; Xun Cheng; Guangwen Wang; Howard Y Chang; Joseph C Wu; Michael P Snyder
Journal:  Circ Res       Date:  2017-06-29       Impact factor: 23.213

10.  The Role of ZEB2 in Human CD8 T Lymphocytes: Clinical and Cellular Immune Profiling in Mowat-Wilson Syndrome.

Authors:  Katie Frith; C Mee Ling Munier; Lucy Hastings; David Mowat; Meredith Wilson; Nabila Seddiki; Rebecca Macintosh; Anthony D Kelleher; Paul Gray; John James Zaunders
Journal:  Int J Mol Sci       Date:  2021-05-18       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.